Please login to the form below

Envision Pharma Group appoints Manish Goel as Global Head of Envision Technology Solutions

Goel will drive the development of innovative technologies, and joins Envision from IQVIA where he served as the VP of Technology Solutions

London, UK, March 18, 2021

Leading global technology-enabled scientific communications company Envision Pharma Group (“Envision” or the “Company”) has appointed Manish Goel as its new Global Head of Envision Technology Solutions (ETS) to drive the development of innovative technologies for the life sciences sector.

Manish Goel brings over 15 years of leadership experience across the technology and healthcare sphere, and joins Envision from IQVIA where he served as the VP of Technology Solutions to lead the development of its customer engagement portfolio of technologies. At Envision, he will focus on the continuing transformation of iEnvision – the global medical affairs platform, solidifying its position as the leading Software as a Service (SaaS) platform and driving the development of innovative and differentiating capabilities for the medical affairs organization.

Goel said, “With COVID-19 accelerating the pace of change in the medical affairs landscape, and the critical, enabling role iEnvision can play here for life science companies, this is an exciting time to join Envision as it embarks on its next phase of strategic growth.”

He added, “I look forward to building on the strength of iEnvision’s existing solutions and customer relationships to deliver market-leading capabilities, that further extend our market position within the medical affairs function.”

David Thompson, CEO, Envision, said, “With his technology pedigree, healthcare experience, and impressive track record, we are delighted to have Manish join Envision. As a proven leader, we look forward to embracing his tremendous expertise in writing the next chapter for iEnvision – establishing it as the gold standard for the medical affairs function as we identify, invest, and develop capabilities that enable us to spread beyond our medical affairs client base.”

-- Ends –

About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision) that have applicability across many areas of medical affairs and related functional responsibility. Envision Pharma Group provides services and technology solutions to more than 90 companies, including all of the top 20 pharmaceutical companies.

Envision has 20 offices: seven in the United Kingdom – Bishop’s Stortford, Glasgow, Horsham, London (Battersea and Hammersmith), Wilmslow, and Alderley Edge; one in Serbia – Subotica; one in Hungary – Szeged; one in Coimbra, Portugal, eight in the United States – Fairfield and Glastonbury, CT, Philadelphia and Wyomissing, PA, Warren, NJ, Boston and Melrose, MA, Powell, OH; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs over 1000 team members, including over 250 highly qualified and experienced in-house medical writers, and 190 technology solutions team members who provide software development and customer support. To find out more, visit

For further information:

Marsha Caplin
Global Head of Marketing
Envision Pharma Group
Tel: +44 (0)7557 083549

18th March 2021



Company Details

Envision Pharma Group

01403 322 000

Contact Website

Envision House
5 North Street
West Sussex
RH12 1XQ

Latest content on this profile

Envision Pharma Group and Alucio™ partner to power next-generation scientific exchange for the life science industry
Collaboration capitalizes on Alucio’s flagship Beacon platform and Envision’s global leadership in medical strategy and healthcare communications
Envision Pharma Group
Envision Pharma Group appoints Head of Envision Value & Access
Envision Pharma Group is pleased to announce the appointment of Mel Formica as its Head of Envision Value & Access.
Envision Pharma Group
Envision Pharma Group appoints new CEO
Meg Heim named as its new Chief Executive Officer
Envision Pharma Group
Envision Pharma Group partners with scite to display Smart Citations in iEnvision® – the global medical affairs platform
Smart Citations will feature in Library, Datavision®, and Scientific Communication Platform modules
Envision Pharma Group
Envision Pharma Group expands capabilities with specialist behavioral science offering Envision the Change

Envision Pharma Group
Envision Pharma Group and Vitaccess create a global partnership to power evidence generation for the biopharmaceutical industry
Move combines Envision’s global leadership position in medical affairs communications with Vitaccess’ award-winning capabilities in real-world evidence (RWE)
Envision Pharma Group